Adult Oxytocin Study (OT)
The Effects of Oxytocin on Social Cognition in Patients With Schizophrenia
Sponsor: San Francisco Veterans Affairs Medical Center
Listed as NCT02577575, this EARLY_PHASE1 trial focuses on Oxytocin and Schizophrenia and remains completed. Sponsored by San Francisco Veterans Affairs Medical Center, it has been updated 8 times since 2010, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Jun 2019 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Nov 2018 — Jun 2019 [monthly]
Completed EARLY_PHASE1
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status EARLY_PHASE1
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting Phase 0
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- San Francisco Veterans Affairs Medical Center
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .